title: Letter to the Editor: Comments on "Sulfonylurea Treatment Before Genetic Testing in Neonatal Diabetes: Pros and Cons" by Carmody D, et al.
authors.affiliation: Paediatric Endocrinology Department, Mafraq Hospital, P.O. Box 2951, AbuDhabi, United Arab Emirates.
authors.forename: Asma
authors.initials: A
authors.lastname: Deeb
mesh_terms: D003922:Diabetes Mellitus, Type 1 / Q000175:diagnosis* / Q000188:drug therapy*; D005260:Female; D005820:Genetic Testing / Q000379:methods*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D008297:Male; D013453:Sulfonylurea Compounds / Q000009:adverse effects* / Q000627:therapeutic use*
chemical_list: D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds